Page last updated: 2024-08-23

pirfenidone and Dilatation, Pathologic

pirfenidone has been researched along with Dilatation, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aquilina, K; Hobbs, C; Thoresen, M; Tucker, A; Whitelaw, A1

Other Studies

1 other study(ies) available for pirfenidone and Dilatation, Pathologic

ArticleYear
Do drugs that block transforming growth factor beta reduce posthaemorrhagic ventricular dilatation in a neonatal rat model?
    Acta paediatrica (Oslo, Norway : 1992), 2008, Volume: 97, Issue:9

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Cerebral Hemorrhage; Cerebral Ventricles; Dilatation, Pathologic; Disease Models, Animal; Losartan; Pyridones; Random Allocation; Rats; Rats, Wistar; Transforming Growth Factor beta

2008